microRNA 4776-1 (MIR4776-1)

microRNA 4776-1 (MIR4776-1) is a human microRNA gene, classified as a small non-coding RNA that modulates gene expression post-transcriptionally. It is not a traditional protein-coding gene or a classical drug target (such as a receptor, enzyme, or transporter). Evidence for specific biological targets or disease associations for MIR4776-1 is lacking, suggesting its biological and clinical significance may be limited or as-yet uncharacterized. microRNA 4776-1 (MIR4776-1) is a small, non-coding RNA molecule of approximately 21–24 nucleotides that acts by guiding the RNA-induced silencing complex (RISC) to partially complementary messenger RNAs (mRNAs), leading to translational repression or mRNA instability[2][3]. MicroRNAs, including MIR4776-1, are critical regulators of gene expression involved in diverse cellular processes—such as development, differentiation, and proliferation—although there is no published information implicating MIR4776-1 in specific pathways, diseases, or as a pharmacological target[4][5]. Note on limitations: - The scientific literature and biomedical databases do not contain reports on unique biological functions, disease roles, or direct drug interactions specific to MIR4776-1. - Many miRNAs have context-dependent roles, but, unless evidence is published, they are not considered conventional drug targets. - If MIR4776-1 is referenced in proprietary or unpublished datasets as a candidate biomarker or target, confirm with primary studies, as the public domain does not support these roles. Summary: microRNA 4776-1 is a non-coding RNA molecule of the microRNA family. It participates in post-transcriptional regulation, but there is no evidence to support it as a recognized drug target, nor is it associated with specific diseases or pharmacological agents at this time[2][3][4].

Other names

hsa-mir-4776-1mir-4776-1MIR4776-1